Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hoffman,
I agree with your list except you left one name off on the right side of the chart and that's thos goofball Dr. Lowenstein. Please add this pathetic human being
Skithoe is 100 % correct on Hy Gro. He's a broken record that keeps playing the same old song without any substance. Everyone should block him and permanently turn him off.
Hy Gro knows he's wrong and by continuing to acknowledge his ignorance gives him satisfaction and a false sense of relevance.
Hy Gro you are not relevant.
Flipper,
Please remind what ECR stands for. Thanks.
To anyone on this board,
Why do I keep having a pop up on my screen for a Territory Food's advertisement. It drives me freaking crazy as I'm reading all of your great posts. It just started doing this a couple of weeks ago.
Any help is much appreciated.
Thanks Muee88 for the directions. Have a great weekend.
Good Evening Fellow Long and some of you Real Long NWBO Investors,
Does anyone have the call in number for Annual Share Holder's Meeting on Monday or do they not have this as an option like a Quarterly Update Call? Please excuse the ignorance and thanks.
Skitahoe,
Please correct me if I'm wrong but the announcement you attached for our CEO speaking at that conference was an open invitation for future meetings. I did not see LP on the agenda. Please check me on that.
By the way I thoroughly enjoy reading your posts. They are insightful and well written with sensitivity. Thanks.
Couldbebetter,
I've worked for three different pharma companies. I started with Abbott Labs for the first 8. I then went to a start up company called CollaGenex Pharma for 8 years similar to the Amarin story and currently working for a Galderma Labs, a derm focus company for the past 8.5 years. We built up CollaGenex with the objective to sell it once we got our first big drug approved and launched. Galderma bought us.
I've worked with nearly every specialty in medicine with the exception of oncology and neurology. Interesting enough though my wife runs an oncology practice. Towards the end of my run at Abbott I did compete in the cardiovascular market specifically in the trig therapeutic area with a fenofibrate.
I've seen this industry change dramatically over the past 30 years. Some change for the better and a lot of change for the worse. What's happened to Amarin in my mind is criminal. Our Justice system has let them and all of us down.
I do believe better days are ahead of us and yesterday's UHC News was huge. I will stand by my post last night.
Good Evening Everyone,
We received what I consider another hope for Amarin and our investment. I pick and choose when to post over the past couple of years but after the UHC announcement today I wanted to share my 2 cents and experience in the pharma industry.
Taking into account everytime we received something positive on Amarin and our investment we then receive something negative. In my opinion this is by far the best news Amarin has received over the past couple of years other than the CVD Risk Reduction Indication.
Please do not view the Prior Approval (PA) that UHC placed on Vascepa as a negative or roadblock for any doctor that wants their patient that meets the criteria to receive Vascepa. This is exactly what we've all been asking fr and wanting. Just give us all of the CVD Risk Indication business with little to no threat of a Generic Vascepa being filled and we are good to go. This will happen for UHC patients that meet the CVD Risk Indication for Vascepa. We all know that the large majority of patientd for our drug.
Also those that are concerned that when a patient's trigs might go below 150 will they approve a patient to stay on Vascepa and the answer is a Resounding Yes. They won't take them off of a drug that has improved their condition and still has risk factors after meeting the criteria to be on the drug.
I've dealt with these types of situations my entire 30 year career in Pharma. What was announced today by UHC should only be viewed as very positive. UHC is a trendsetter and many other MC Plans will follow as the word gets out.
Wha we need now is the CAFC to uphold their ruling in favor of GSK and this battle is just about over and justice has been served for the Amarin Corporation and all of us.
It's been a long road but for the first time I see a bright light shining for Amarin, the Science and all of us.
Pharma Girl,
You make a very good point regarding why UHC will save employers a lot of money in the long run by keeping their employees healthy by having them take drugs that have been proven to reduce CVD events. This is why every corporation's HR Department is constantly pushing preventative and wellness programs on their employees every year. The company I work for is constantly offering up these types Program.
Sleven,
They will restrict a generic product to an approved indication on a occasion especially if the price of the generic is not much less than the brand. Also the market size of the therapeutic area where the generic is indicated will play a role in their decision.
Raf,
As a 30 year Pharma industry person I quickly thought of the same question and scenario why UH would not possibly allow Vascepa for a patient with trigs and over 500 with at least 1 CVD Risk Factor. That does not make a bit of sense to me.
I agree with you 100 percent that will be temporary or they will move forward right away and approve PA's for patients that have trigs over 500 with CVD Risk Factors.
Folks this is very good news for Amarin and us. We all know United Healthcare is one of the largest manage care plans in the US. In my opinion this will be a dominoe affect started by UH pushing the ball first towards the first dominoe. The remaining manage care plans will follow one by one.
Does anyone have the link to the oral arguments yesterday for the GSK vs Tea appeals case? Thanks.
Good Saturday Everyone,
Just as an FYI for those that are not in the Pharma Industry like a few of us on this board during the First Quarter of each year a lot of Pharma brands Rx growth are flat to negative. The reason being is because the large majority of insured patients are now on deductible plans and everyone starts over on January 1. So what does this actually mean? Basically a lot of patients will make sure they get their refills by the end of the previous year because they have already met their deductible knowing that it starts over at the beginning the next year. I see it each year with a lot of our brand at the company I work for. It's become common knowledge in the pharma industry so the forecasting methodology has changed where a lot of Pharma companies forecast lighter Rx Volume numbers in Q1 and increase the Rx forecast as the year progresses especially during Q4.
Now I'm not pretending to support Amarin 100 percent on why they have not been able to grow their business over the past year plus. However, I'm a realist after being in this industry for 30 years and know first hand the major changes and challenges companies are now facing in this industry. In addition to the above mentioned experiences mentioned Amarin has endured even more challenges than most pharma companies over the past 12 months. Pandemic, Losing the Patents for US business in both Nevada and CAFC courts, Generics entering the US Market and the list goes on and on for this poor company.
I agree with many of you on this board management has made some calculated mistakes along the way but man have they been dealt a bad hand of cards a few times along the way on their mission to change the way the world treats cardiovascular disease with solid science to back it up.
Just I like the rest of you I have several thousand shares that are upside down right now and í continue to wait for the European Approval, China approval and then hopefully they do the right thing and sell the company and we at a minimum get our money back plus some profit.
Everyone have a great weekend. Stay safe, warm and healthy. We are finally starting to thaw at here in DFW. The sun is out today so life is good. Take care.
Sleven,
What actually is the court document saying that was just released?
Steven,
Louie,
Glad you are ok and back Posting. Bio must be planning his his explosive return. I'm not sure I ever heard what sent him to jail. He must have really gone off of the rails. I do enjoy his posts most of the time. Take care
Lizzy,
I'm not sure where Louie went. I do know Bio was incarcerated for a while but the date to get out of jail I believe has passed.
Anyone know if Billionaire is still in the IHUB Jail?
Does anyone know Bio Billionaire gets out of the IHUB Jail?
Good Sunday to Everyone,
I've been out of the loop for a few days. What the hell did Biobillionaire say or do this time that landed him in I-HUB Jail? I do miss his commentary. He's never said a thing he did not believe or have 100 percent conviction in.
Doc Logic,
Always my pleasure to contribute to this team. I realize how difficult it can be to play the waiting game with these types of investments. I ground myself to the science and hope in the end that wins out most of the time. There is no guarantee but I for one believe we all know what the final outcome is going to be with NWBO and we are going to have one massive celebration.
Happy Librarian,
R-E-L-A-X. You are speculating with no factual information at all. There is a plan in place that NWBO is executing at the current time and currently has no new information that can or should be shared with us as investors. The are in negotiations with regulatory agencies and advisors. They are not and should not risk anything at this point. I've been in the pharma industry for over 30 years. This is exactly what NWBO Senior Management should be doing at this point. Yes the lack of communication to investors suck but there is a reason why they are in a quiet and period. Enjoy the ride bro.
I realize you have or were burned a few years ago with NWBO but we are not there any longer. Be patient and enjoy this ride. The best is yet to come and just around the corner.
Fellow NWBO Investors,
I've been an investor in NWBO since last spring so not near as long as many of you. I feel your pain though as a 11 year Investor of Amarin.
Ive been in the pharmaceutical industry for over 30 years now so I have a good idea how the regulatory, sales and marketing areas of this industry works. I'm not a legal expert.
I understand many of your frustrations recently with NWBO's Senior Management and their lack of communication.
I had a 30-45 minute long conversation with their investor relations person today. I expressed many of your concerns and allowed him to share the reasons why there has not been much, if any, communication over the past 60 days. Everything he shared with me is 100 percent in line with my experience over the past 30 years in this industry in various high-level positions. Yes they are in a quiet period as it relates to financials and regulatory topics and questions. Reason because they are in deep and high-level discussion with the FDA and other significant stakeholders.
Bottom line there is absolutely nothing right this second that would be material that they could announce or communicate with us the investors. It was crystal clear from my conversation and I agree this should under no circumstance be perceived or taken as negative. They are working tirelessly with both regulatory agencies,KOL's, Advisors, Experts and top peer reviewed medical journals to finalize the announcement of TLD.
For those who believe everything you read from scumbags like Adam FartStain it's time to wake up and ignore losers like that SOB.
LP announced at a small charity event back in early October they would be locking the data and then it would be sent to the statisticians. Adam FartStain reported back in September NWBO had already been unblinded to the data and new it was not good. The company cannot be unblinded until the data is locked and it goes to the statisticians. This is why he's a scumbag and misleads uninformed investors.
I honestly believe NWBO is real close to releasing TLD along with which prestigious and credible peer review journal will be publishing the results. This takes a lot of time especially in the virtual world we are navigating through currently. Their IR Guy told me today there are so many moving parts going on right now and the last thing Senior Management would want to do is send a communication on something that potentially would screw it up for them after all of these years. He basically said right now there is nothing new they could communicate to their investors. I mentioned many of you on these message boards are struggling with the lack of communication and updates. While they are sensitive to that they realize they are so close after all of these years to achieving major milestones and hundreds of millions dollars they invested in clinical trials have chosen to wait until they have everything ready to go and meaningful information to share with us. Also he mention the silence and lack of communication should not be perceived or taken as negative that they know the data is bad or the financials are a mess etc.
So as a fellow investor my suggestion is if you invested in NWBO because of the science as I definitely did be patient and let the review of the science take us to the finish line.
The Best is Yet to Come.
Would someone please post the Weekly Rx numbers? From what I'm reading they must have not been impressive. Thanks
Ralphey,
You are not providing accurate information on Vascepa coverage. Vascepa is not being rejected 80 percent of the time. No way. I've been on it for over 2 years and never pay more than $9 for a 3 month supply using their copay card. It's covered on over 75 percent of US Manage Care Plans. Show us the proof bro.
Would someone please post the West conducted with Dr. Javitt today? Thank you.
Lem,
Where did you read that Yasmine put out the $21 target again?
Isaeed,
Where did you see and confirm the Tea and GSK case was remanded back to the district court? Or are you asking?
VuBru Lol. typo. Neurology
Thank you VuBru. This definitely sounds significant the way you outlined it below.
Thanks Doc Logic. If I understand you correctly by accepting the endpoint changes and moving them around and comparing them to SOC this dramatically increases the likely hood of NWBO receiving approval. Would this be for both Europe and USA? Thanks.
Thank you MI Daydream for the thorough update. I'm still trying to wrap my brain around NWBO's GBM Study. I've been in the Pharma Industry for over 29 years and worked with every specialty with the exception of numerology and oncology so the designs of this study and being able to interpret everything including all of the acronyms everyone is using using on their comments is a challenge. I appreciate you.
Would someone please share what occurred over the weekend specifically regarding the Study Endpoints being changed and how this is being viewed positive by the investment community? I was extremely busy this weekend and missed everything regarding the news. I greatly appreciate it.
Thanks Raf.
Would someone please post the Markamn Article? I have been slammed today and just now catching up. Thank you.
Rose,
Unfortunately you are most likely correct. It's just a travesty that 4 Judges that does not know a damn thing about drug clinical research and analysis can ruin a small company that spent hundreds of millions of dollars to prove how their drug will save hundreds of millions of lives. They won't even get a chance at least in the US to reap their just reward.
Bill B,
You are spot on about NWBO. Everything is pointing to a positive release of their Phase 3 Data for Glioblastoma that has been ongoing for 13 years. I honestly believe their drug is going to change how they treats many types of cancer. This company is going to be ripe for a a Big Pharma who has a history of being in Oncology to pick off. I increased my share count to 10,000 today.
Well my fellow Amarin Investors, not that the following softens the blow that we took 2 weeks ago nor is it a surprise because we all know the clinical value of Vascepa but I received my blood work back today and my Trigs went down from 205 to 105 in 6 months. I've been on Lipitor for over 20 years and Vascepa for over 2 years. I will have a heart scan as part of my Executive Physical next Monday. I had a baseline scan 2 years ago and I fully expect the scan to show plaque regression.
This is just one of a million examples that Vascepa is a Game Changer and Amarin deserves the right to market the drug for several more years without generic intrusion. It
Continues to burn and eat me up every time I think of our judicial system.
As I have mentioned a few times on this board I've been in Pharma for over 29 years and have actually gone through what Amarin is going through but none of my drug experiences were as criminal as to what our legal system is doing to Amarin.
In the back of my mind I keep a small glimmer hope someone within the US Legal System will Right this horrible and unfair Wrong.
Ilovetech and Bill B,
I agree with you Ilovetech there is no basis to that Yahoo Post on NWBO. The post was written in a way that the person was in the mind of the CEO and had hidden meanings for what she was saying about the Phase 3 Data
On another note I would live both of your thoughts on anything you've read on the interim data when it was presented and published a couple of years ago and the direction of the company. I bought a few thousand shares a couple of months ago when the PPS was just .36 cents. I'm learning everyday a bit more about the company and the rest drugs they have in the works especially the one on for Glioblastoma which is close.
Thanks for sharing any expertise and knowledge.
Thanks Eight